Hailong Hu

Department of Urology, The Second Hospital of Tianjin Medical University

Affiliated withThe Second Hospital of Tianjin Medical University Tianjin Institute of Urology

Research Area

Biography

Hailong Hu has not added Biography.
If you are Hailong Hu and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2024

Other Publications

Article	Year
[Diagnosis and treatment of xanthogranulomatous prostatitis: a case report and review of the literature]. Zhonghua nan ke xue = National journal of andrology\| PubMed ID: 23441457	2013
Genetic variations rs11892031 and rs401681 are associated with bladder cancer risk in a Chinese population. International journal of molecular sciences\| PubMed ID: 25347272	2014
Expression of brain‑specific angiogenesis inhibitor‑1 and association with p53, microvessel density and vascular endothelial growth factor in the tissue of human bladder transitional cell ca... Molecular medicine reports\| PubMed ID: 26129954	2015
Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer. Biochemical and biophysical research communications\| PubMed ID: 26551459	2015
Association between MDM2 SNP309 T>G polymorphism and the risk of bladder cancer: new data in a Chinese population and an updated meta-analysis. OncoTargets and therapy\| PubMed ID: 26672516	2015
Risk Factors Predictive of Recurrence and Progression for Patients Who Suffered Initial Recurrence After Transurethral Resection of Stage pT1 Bladder Tumor in Chinese Population: A Retrospec... Medicine\| PubMed ID: 26844474	2016
Intravenous chemotherapy combined with intravesical chemotherapy to treat T1G3 bladder urothelial carcinoma after transurethral resection of bladder tumor: results of a retrospective study. OncoTargets and therapy\| PubMed ID: 26869805	2016
The evaluation of the association between the metabolic syndrome and tumor grade and stage of bladder cancer in a Chinese population. OncoTargets and therapy\| PubMed ID: 27022277	2016
The value of extensive transurethral resection in the diagnosis and treatment of nonmuscle invasive bladder cancer with respect to recurrence at the first follow-up cystoscopy. OncoTargets and therapy\| PubMed ID: 27103828	2016
Biological effects of eukaryotic recombinant plasmid pReceiver-M61-BAI-1 transfection on T24 cells and HUVECs. Molecular medicine reports\| PubMed ID: 27356780	2016
Polymorphism in IGFBP3 gene is associated with prostate cancer risk: an updated meta-analysis. OncoTargets and therapy\| PubMed ID: 27462171	2016
The comparison of perioperative outcomes of robot-assisted and open partial nephrectomy: a systematic review and meta-analysis. World journal of surgical oncology\| PubMed ID: 27549155	2016
Prognostic significance of urothelial carcinoma with divergent differentiation in upper urinary tract after radical nephroureterectomy without metastatic diseases: A retrospective cohort stu... Medicine\| PubMed ID: 28538387	2017
Preoperative hemoglobin-platelet ratio can significantly predict progression and mortality outcomes in patients with T1G3 bladder cancer undergoing transurethral resection of bladder tumor. Oncotarget\| PubMed ID: 29719631	2018
Selective Actionable and Druggable Protein Kinases Drive the Progression of Neuroendocrine Prostate Cancer. DNA and cell biology\| PubMed ID: 29969286	2018
Neural precursor cell expressed, developmentally downregulated 8 promotes tumor progression and predicts poor prognosis of patients with bladder cancer. Cancer science\| PubMed ID: 30407690	2019
RAB38 promotes bladder cancer growth by promoting cell proliferation and motility. World journal of urology\| PubMed ID: 30535713	2019
KIF5A Promotes Bladder Cancer Proliferation and . Disease markers\| PubMed ID: 31354888	2019
Laparoscopic treatment of a huge seminal vesicle calculus: A case report and review of literature. Experimental and therapeutic medicine\| PubMed ID: 31798705	2019
Protein kinase TTK promotes proliferation and migration and mediates epithelial-mesenchymal transition in human bladder cancer cells. International journal of clinical and experimental pathology\| PubMed ID: 31949560	2018
Expression of circular RNA circASXL1 correlates with TNM classification and predicts overall survival in bladder cancer. International journal of clinical and experimental pathology\| PubMed ID: 31966702	2017
Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients. Cancer medicine\| PubMed ID: 32250047	2020
Expression and Prognostic Significance of the MMP Family Molecules in Bladder Cancer. Combinatorial chemistry & high throughput screening\| PubMed ID: 32940175	2021
Long noncoding RNAs, ENST00000598996 and ENST00000524265, are correlated with favorable prognosis and act as potential tumor suppressors in bladder cancer. Oncology reports\| PubMed ID: 33000254	2020
Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinoma. Cancer science\| PubMed ID: 33047430	2021
Circ_0030586 inhibits cell proliferation and stemness in bladder cancer by inactivating the ERK signaling via miR-665/NR4A3 axis. Acta histochemica\| PubMed ID: 34175686	2021
CRTAC1 (Cartilage acidic protein 1) inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) process in bladder cancer by downregulating Yin Yang 1 (YY1) ... Bioengineered\| PubMed ID: 34818994	2021
Upregulated Transcription Factor PITX1 Predicts Poor Prognosis in Kidney Renal Clear Cell Carcinoma-Based Bioinformatic Analysis and Experimental Verification. Disease markers\| PubMed ID: 34868397	2021
Low-dose hexavalent chromium(VI) exposure promotes prostate cancer cell proliferation by activating MAGEB2-AR signal pathway. Ecotoxicology and environmental safety\| PubMed ID: 35660381	2022
The CUSUM curve combined with comprehensive complication index for assessing short-term complications of radical cystectomy. Journal of clinical laboratory analysis\| PubMed ID: 35881663	2022
Construction of an Epithelial-Mesenchymal Transition-Related Model for Clear Cell Renal Cell Carcinoma Prognosis Prediction. Disease markers\| PubMed ID: 35983409	2022
The efficacy and safety of first-line treatment in cisplatin-ineligible advanced upper tract urothelial carcinoma patients: a comparison of PD-1 inhibitor and carboplatin plus gemcitabine ch... Oncoimmunology\| PubMed ID: 36148322	2022
Corrigendum to "Circ_0030586 inhibits cell proliferation and stemness in bladder cancer by inactivating the ERK signaling via miR-665/NR4A3 axis" [Acta Histochem. 123(5) (2021) 151745]. Acta histochemica\| PubMed ID: 36180249	2022
Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer. Frontiers in oncology\| PubMed ID: 36300085	2022
CircSTK39 suppresses the proliferation and invasion of bladder cancer by regulating the miR-135a-5p/NR3C2-mediated epithelial-mesenchymal transition signaling pathway. Cell biology and toxicology\| PubMed ID: 36538242	2023
Association of metabolic syndrome and its components with the risk of kidney cancer: A cohort-based case-control study. Technology and health care : official journal of the European Society for Engineering and Medicine\| PubMed ID: 36617800	2023
Construction and validation of a bladder cancer risk model based on autophagy-related genes. Functional & integrative genomics\| PubMed ID: 36689018	2023
Enhancing urinary tract infection diagnosis for negative culture patients with metagenomic next-generation sequencing (mNGS). Frontiers in cellular and infection microbiology\| PubMed ID: 36936777	2023
Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real-world study. Cancer medicine\| PubMed ID: 36952461	2023
Neoadjuvant therapy with camrelizumab plus gemcitabine and cisplatin for patients with muscle-invasive bladder cancer: A multi-center, single-arm, phase 2 study. Cancer medicine\| PubMed ID: 37021811	2023
circSOBP Inhibits Bladder Cancer Proliferation and Metastasis by Regulating the miR-200a-3p/PTEN Axis and Participating in the Immune Response. Cell transplantation\| PubMed ID: 37026617	2023
Comprehensive characterization of endoplasmic reticulum stress in bladder cancer revealing the association with tumor immune microenvironment and prognosis. Frontiers in genetics\| PubMed ID: 37091788	2023
Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data. Heliyon\| PubMed ID: 37346342	2023
Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics data. Functional & integrative genomics\| PubMed ID: 37358720	2023
Withdrawal notice to: "Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data" [Heliyon 9, (2023) 16897]. Heliyon\| PubMed ID: 37484247	2023
Association of metabolic syndrome and its components with the risk of urologic cancers: a prospective cohort study. BMC urology\| PubMed ID: 37736725	2023
Clinical outcomes of immune checkpoint inhibitor plus nab-paclitaxel in metastatic upper tract urothelial carcinoma. Translational andrology and urology\| PubMed ID: 37814696	2023
Construction and Validation of a Prognostic Model Based on Pyroptosis-related Genes in Bladder Cancer. Combinatorial chemistry & high throughput screening\| PubMed ID: 37849225	2024
Construction and validation of a metabolism-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer. BMC medical genomics\| PubMed ID: 37880682	2023
Identification and validation of a dysregulated TME-related gene signature for predicting prognosis, and immunological properties in bladder cancer. Frontiers in immunology\| PubMed ID: 37965307	2023
SPP1 mRNA determination based on molecular beacon for the recurrence prognosis of bladder cancer. Translational andrology and urology\| PubMed ID: 38196702	2023
Electrocardiographic characteristics of bladder cancer patients receiving preoperative chemotherapy combined with immunotherapy. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc\| PubMed ID: 38288514	2024
Is switching intravesical chemotherapeutic agents beneficial in short-term recurrent high-risk non-muscle-invasive bladder tumors? A 5-year retrospective study. BMC urology\| PubMed ID: 38297256	2024
Clinical effectiveness of a multitarget urine DNA test for urothelial carcinoma detection: a double-blinded, multicenter, prospective trial. Molecular cancer\| PubMed ID: 38504268	2024
The prognostic values and immune characteristics of polo-like kinases (PLKs) family: A pan-cancer multi-omics analysis. Heliyon\| PubMed ID: 38560150	2024
Phase 2 Study of Preoperative Tislelizumab in Combination with Low-dose Nab-Paclitaxel in Patients with Muscle-invasive Bladder Cancer. European urology oncology\| PubMed ID: 38762368	2024
The prognostic impact of tumor location in nonmuscle-invasive bladder cancer patients undergoing transurethral resection: insights from a cohort study utilizing Chinese multicenter and SEER ... International journal of surgery (London, England)\| PubMed ID: 38788195	2024
The prognostic significance and immune characteristics of bone morphogenetic proteins (BMPs) family: A pan-cancer multi-omics analysis. Technology and health care : official journal of the European Society for Engineering and Medicine\| PubMed ID: 39031404	2024
An integrated pan-cancer assessment of prognosis, immune infiltration, and immunotherapy response for B7 family using multi-omics data. Life sciences\| PubMed ID: 39034028	2024
Targeted Inhibition of Lymphovascular Invasion Formation with CREKA Peptide-Modified Silicasomes to Boost Chemotherapy in Bladder Cancer. Nano letters\| PubMed ID: 39136297	2024
Bioinformatics analysis of ERCC family in pan-cancer and ERCC2 in bladder cancer. Frontiers in immunology\| PubMed ID: 39192988	2024
Comparison of Superselective Renal Artery Embolization versus Retroperitoneal Laparoscopic Partial Nephrectomy in Ruptured Hemorrhagic Renal Angiomyolipoma: A Single-Center Study. Diseases (Basel, Switzerland)\| PubMed ID: 39329887	2024